Luana Colloca, MD, PHD, MS: Researcher of the Year
Luana Colloca, MD, PhD, MS, first became fascinated with the placebo effect and pain management when she was in medical school.“I was captivated by the brain’s functions, especially how little we know about its role in healing and how it influences the perception of pain-related symptoms,” said Colloca, professor, Department of Pain and Translational Symptom Science, University of Maryland School of Nursing (UMSON), and University of Maryland MPower professor.Colloca is an international expert in the fields of placebo effect and nocebo effect — the opposite of the placebo effect in which instead of having a positive response, patients have negative outcomes to treatments that cannot be explained by the treatments’ pharmacologic effects — and mechanisms of pain modulation. She has secured multiple National Institutes of Health awards, including several R01 grants and an R21 grant. For her pioneering work, Colloca has been named the University of Maryland, Baltimore (UMB) 2024 Founders Week Researcher of the Year.Learn more: https://www.umaryland.edu/founders/founders-week-award-winners/researcher-of-the-year/
More from Youtube
- 0:53Provisional Licenses & Teen Driver Safety | Breakthroughs Can't WaitDo provisional licenses reduce teen driving risks?University of Maryland, Baltimore researchers are evaluating how policy impacts crash rates among young drivers — with support from NHTSA.#TeenDrivers #TrafficSafety #NHTSA #ProvisionalLicense #RoadSafety #BreakthroughsCantWaitUMB
- 4:50How Can We Keep Young Drivers — and Others — Safe? | Breakthroughs Can't WaitEvery year, thousands of young lives are lost on U.S. roads.For Kerri McGowan Lowrey, JD, MPH, that’s not just a statistic. It’s also a public health crisis that calls for data-driven solutions.As deputy director of the Network for Public Health Law’s Eastern Region office at the University of Maryland Francis King Carey School of Law, Lowrey partnered with the National Highway Traffic Safety Administration to examine how driver licensing laws impact teen safety. Her team applied a method known as legal epidemiology — quantifying laws so researchers can evaluate their real-world effects on health and safety.Learn more at https://www.umaryland.edu/breakthroughs#TrafficSafety #DriverPolicy #NHTSA #PublicHealth #SmartDriving #BreakthroughsCantWaitUMB
- 0:55Smarter Driver Training for Safer Roads | Breakthroughs Can't WaitSmarter drivers make safer roads.Researchers at the University of Maryland, Baltimore are helping improve how drivers learn — using data, technology, and behavioral science.This research at Maryland Carey Law is supported by the National Highway Traffic Safety Administration (NHTSA).#RoadSafety #DriverTraining #NHTSA #TrafficSafety #BehavioralScience #BreakthroughsCantWaitUMB
- 0:35New Cancer Treatment: Ultrasound Opens the Brain to ChemoOnly 2% of cancer drugs can reach the brain — but that could change.At UMB, researchers use focused ultrasound before and after brain tumor surgery to open the blood-brain barrier, helping chemo reach where it couldn’t before.Supported by the National Cancer Institute and the National Institute of Neurological Disorders and Stroke, both within the NIH.#CancerResearch #BrainTumor #NIH #FocusedUltrasound #NCI #NINDS #BreakthroughsCantWaitUMB
- 0:54Breakthrough Therapy: Opening the Blood-Brain BarrierAt the University of Maryland, Baltimore, researchers are breaking through one of medicine’s greatest challenges: safely opening the blood-brain barrier to deliver therapies.This breakthrough — supported by the National Cancer Institute and the National Institute of Neurological Disorders and Stroke at the NIH — could transform treatment for brain tumors and neurological diseases.#BrainResearch #BloodBrainBarrier #NIH #NCI #NINDS #MedicalBreakthrough #BreakthroughsCantWaitUMB
- 1:01Focused Ultrasound Enhances Brain Tumor TreatmentCan we treat brain tumors with ultrasound waves?Researchers at the University of Maryland are making it possible — with a new drug delivery method that targets brain tumors directly.This research is supported by the National Cancer Institute and the National Institute of Neurological Disorders and Stroke, both part of the NIH.#BrainTumor #CancerResearch #NIH #NCI #NINDS #MedicalBreakthrough